title: Diagnostic scoring for familial hypercholesterolaemia in practice.
abstract: Diagnostic scoring for familial hypercholesterolaemia (FH) can be used either to screen for possible FH or guide the selection of patients for genetic (DNA) testing. We review the published diagnostic criteria and discuss the options for future development.
  
  
  
  Scoring systems have been developed internationally based on lipid values and various combinations of clinical signs and cardiovascular history. The predictive value varies according to the test population, be it lipid clinic referrals, general population, or relatives of patients with FH. Also, there is increasing recognition of genetic heterogeneity in FH so that criteria are of differing predictive value depending on the genetic variant of FH.
  
  
  
  These clinical scoring systems are increasingly used to guide selection of patients for FH genetic testing but no single approach has yet emerged as the system of choice. Further refinement of these scoring tools using more sophisticated calculators are superseding the more manual approaches. These are well suited to web-based tools or smartphone applications.
authors.affiliation: aCardiff UniversitybCardiff and Vale University Health Board, Cardiff, UK.
authors.forename: Kate
authors.initials: K
authors.lastname: Haralambos
authors.forename: Pauline
authors.initials: P
authors.lastname: Ashfield-Watt
authors.forename: Ian F W
authors.initials: IF
authors.lastname: McDowell
mesh_terms: D000367:Age Factors; D015415:Biomarkers / Q000378:metabolism; D019937:Diagnostic Techniques and Procedures / Q000592:standards*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000150:complications / Q000175:diagnosis* / Q000378:metabolism; D012737:Sex Factors
chemical_list: D015415:Biomarkers